Amel Kime
Papers
1
Total Citations
7
H-Index
1
About
Amel Kime is a dedicated clinical researcher whose work centers on urologic oncology and rare genitourinary pathologies. Her most-cited contribution, a 2024 systematic review on inflammatory myofibroblastic tumors (IMTs) of the urinary bladder, addresses a critical gap in clinical practice. By synthesizing case data, Kime’s review provides the first comprehensive comparison of management options for this rare, intermediate-grade lesion, which is prone to recurrence but lacks formal treatment guidelines. This work has already garnered 7 citations, signaling its importance to surgeons and oncologists navigating uncertain clinical terrain. Beyond this flagship study, Kime’s research portfolio reflects a commitment to improving diagnostic clarity and therapeutic strategies for understudied urologic conditions. Her systematic approach and focus on evidence synthesis make her a valuable voice for clinicians seeking data-driven guidance on rare tumors. As she continues to publish, Kime is poised to shape future consensus statements and clinical pathways in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1